<<

Agenda -related Emergencies 1. Background Blood and breath alcohol levels .2 ۃƱࢽூ ߍ࡯շጳ่ 3. ED evaluation and management 4. Alcohol withdrawal 5. Alcoholic

Background Epidemiology

  or abuse  over time, the person must consume more  40% ED patients alcohol to achieve the same intoxicating effects  25~40% trauma patients  Alcohol dependence  develops withdrawal symptoms with cessation of alcohol  Alcohol addiction  drastic behaviors used to maintain alcohol intake and often involves socially inappropriate behavior

Epidemiology Pharmacokinetics And

 Beneficial: 2~6 drinks per week  Absorption:  Harmful: > 2 drinks per day  20% in stomach, 80% in small intestine  Metabolism:  In general, one drink  Liver (90%), kidneys, lungs = 1 ounce of hard liquor  Alcohol dehydrogenase (ADH), = 1 beer  Microsomal -oxidizing system = 1 glass of wine (MEOS)  = 25 mg/dL blood alcohol level (BAL) Peroxidase-catalase system Rate of ethanol metabolism = risk factor

 Non-tolerant adult: 20 mg/dL/h  Trauma:  Chronic drinkers: 30 mg/dL/h  speeding, not wearing seatbelts (induction of the MEOS system)  falling  Rule of thumb:  fighting  25 mg/dL/h (USA)  20 mg/dL/h (Taiwan)  Alcohol hypersensitivity  Asians  Facial flushing – high aldehyde level

Alcoholism = risk factor Prehospital Care

 Non-trauma :  EMS transport  pneumonia, lung abscess, meningitis  If > 5 times: 71% alcoholics  cardiomyopathy  Refuse treatment or transport  coagulopathy  If altered mental status:  suicide  Check blood sugar  Protect cervical spine  Prevent aspiration

Initial evaluation in ED Initial evaluation in ED  Secure ABCs - when in doubt, a  Secure ABCs - when in doubt, a definitive airway should be secured definitive airway should be secured  If AMS  If AMS  Protect and clear C-spine  Protect and clear C-spine  Monitor SpO2  Monitor SpO2  Check blood (esp. children)  Check blood glucose (esp. children)  Give 100 mg (Wernicke’s  Give thiamine 100 mg (Wernicke’s encephalopathy) encephalopathy)  Naloxone [X], flumazenil [X] History  ʍᾐI0ҧዔǑဇ1  ྘ࠤɐᎹȝમᚳፗ໇̐⁄໚⊮  PHx: disulfiram, warfarin, phenytoin,  Prior withdrawal seizure  Abdominal pain, tachypnea  Alternative drinks – wood / rubbing alcohols

PE Sobriety Tests

 Complete secondary survey  Field / boating sobriety test (> 100  Horizontal nystagmus mg/dL)   Serial NE, esp. if multiple caretakers Horizontal gaze nystagmus  Difficulty reciting alphabet from A to Z  Chronic alcoholics:  Difficulty with clapping hands while  rhinophyma, palmar erythema, spider counting angiomata, hepatomegaly, testicular atrophy, “chipmunk cheeks” (parotid enlargement), gynecomastia, acne rosacea, Dupuytren’s contractures

Sobriety Tests Blood Alcohol Levels

 Detect breath odors  BALs correlate poorly with the degree  Significant rate of false-negatives. of intoxication observed clinically (e.g.  Failing to detect alcohol (false-negative), using Alcohol Symptom Checklist) not in overestimating its presence (false- positive)

 Alcohol Symptom Checklist (a clinical scoring tool) did not correlate with the blood alcohol in intoxicated patients ዚ╖ΨৈᙊǏἜᡛܾJǞҥ̊ᱜἜࠉᦇ ᕭଗ

ৈᙊዚ╖ᡛܾ üᒻዚ╖ᡛܾ ṟ᭘  ᭝᭣̊ᆺ৔ᒻጺᯟ໚⊛ዚ╖ᡛܾᑧǔί ǕΫƫͻۻmg/100mL) (mg/L) P˜ˤᒃƳ̵ɚ⊛ҟਲ਼ߝ่p) ╖⇶Ꮋࢃ⊛ᖀধ̃'ʌ๏̃ᚳΞ⊛ ଩ʞ̃ഒҧ ɐִǑΫƫ̵ɚøᓸ⊛ḎÌ∙ᏺǞ᭝᭣⊛J 0.238~0.047 50~10 ΐȆમᔶᣤ⊛Ȕȑμేʅ̃Wಥ⊛ Šૻ᭝᧿Ǖsྠ (ᇛཷ˴ᆢСǐଗʯ⏄ɐ἖ɐΩ͛ᄵJᇛཷ˴ 50~100 0.238~0.467 M੡ᇺ᎕ ᆢ␹Პߝøᄵϛ⏄əΩˤᄵଗв) ╖⇶ᒷ˒⊛܋৩ষWಥ⊛ஈ௦ɝ᚝⊛ 150~300 0.714~1.428 в‘̃ᠤ↱⊛ষୂᠤ↱  ᭝᭣̊ᒻ໚ዚ╖ᡛܾᇜPˤˤᒃƳ̵ɚ⊛ ວÆ'࿀ŝ'ວΌ'Ȕȑljే຦᧷⊛ ᭝᭣̊ҟ̵ϙыǔǙСǐò⊛ߝɐ܌̵ɛྡ 250~400 1.190~1.904 ƿҧ'lj∙ ࠪɹ'୰ࠑમߝ̵əִƫ̵ɚἜøፙ (ɹᕭྷ ວᅿ⊛Фǐlj;ধೠ⊛ü¸ࡂᵈߣ ⏄ɐ἖ǓΩˤᄵʛə) 400~500 1.904~2.380 ʳ'ᐓ˱

ஐ␯⚌Ś ¹ᒻΏৈᙊɽዚ╖ᡛܾȚΥˢᾐ౳␯⊮

 ᚉƴ᡾໚ἔᶷ˴ᆢ˛ෝᆋᡪᲖÌ⊛ͻɚΰǕ  üᒻዚ╖ᡛܾ x 200 = ৈᙊዚ╖ᡛܾ ໚૥ఽW೮๑ዚ╖ጺᛄ⊛☫ᛄɢüᒻዚ╖ᡛ  0.25 mg/L x 200 = 50 mg/dL ܾᥒ 0.20 mg/L⊛౓Ǐ˛ෝἔᶷ໚⊛̦Ἔ  0.55 mg/L x 200 = 110 mg/dL ৈᙊዚ╖ᡛܾ໇Ʋҩ⊮  ৈᙊዚ╖ప៬(̳ಥ)ᰟ  ᑧҧ໚10~40 mg/dL  z␯o᷀܋χ⊩20 mg/dL/hr

BAL and GCS

 GCS is not statistically affected by the presence of alcohol until the BAL is 200 mg/dL or more  Indications of head CT:  BAL < 200 mg/dL and GCS ≤ 14  GCS ≤ 13 When to obtain BAL Laboratory Testing

 Routine BAL:  Glucose: F/S  The American College of Surgeons’  K Committee on Trauma recommends  Mg drug and alcohol screening as “essential” for level I and II and “desirable” for level  Amylase, lipase III trauma centers  Elevated  Recommended if:  Clinically diagnosis  diagnosis of intoxication is uncertain  clinical evidence of head injury

Head CT CT for alcoholics

 Clinical evidence of skull fracture  Either:  Basilar skull fracture: periorbital ecchymosis (raccoon’s eyes), mastoid ecchymosis (Battle’s sign), 1. Liberal policy of CT (head, chest, CSF otorrhea or rhinorrhea, hemotympanum abdomen)  Palpable skull fracture  Major mechanism of injury and altered mental status 2. Admission for close observation or  Level of consciousness more depressed than expected prolonged observation with frequent compared to the serum alcohol level serial re-examination / ultrasound  Significantly altered mental status (GCS ≤ 13) and evidence or suspicion of head trauma  Falling GCS  Focal neurologic deficit

Cervical Spine Radiography ED management

 NEXUS study: intoxicated patient can  Physical or chemical restraints have asymptomatic CSI  agitation  Recommendation:  disruptive to staff  minimum of 3 views or be maintained in  potentially threaten their own well-being spinal precautions until sober  restless or combative – consider succinylcholine and intubation in high- risk patients (e.g. thrown through the windshield) Chemical restraints Alcohol withdrawal syndrome

  AWS develops 6~24 hrs after a decrease in – combative / withdraw ethanol intake and lasts from 2~7 days  Mild symptoms: irritability and  Lorazepam sleeplessness  Dormicum  Major withdrawal:  Butyrophenones  Fever, diaphoresis, and hallucinations  Autonomic hyperactivity - tremulousness, – behavioral emergencies sweating, , vomiting, and agitation  Haloperidol  Vital signs - elevated HR and BP  Droperidol  Generalized seizures (rum fits), within 12~24 hrs of abstinence

Delirium tremens DDx of

 3rd~4th post-abstinence day  Metabolic disorders  5% of AWS  Hypoxia  S/S  Hypoglycemia  Hallucinations – visual, tactile (formication)  Hyperthyroidism  Confusion, disorientation  Hepatic encephalopathy  Pronounced autonomic hyperactivity –  Infectious disasters adrenergic storm  Sepsis  Tx = benzodiazepines  Meningitis  Mortality less than 15%  Encephalitis

BZD for AWS AWS: adjunctive treatments

 Drug of choice = lorazepam  Haloperidol, droperidol  Ease of administration, rapid onset of  ß-blockers, clonidine, carbamazepine action, non-hepatic metabolism, and lack  Alcohol detoxification units - only for of active metabolites those who have stable vital signs and  IV dose: 2~5 mg bolus, 2~5 mg q20min are not hallucinating or confused  When using BZDs, avoid switching agents but instead administer repeated doses of a single agent Rum fits Alcoholic ketoacidosis (AKA)  Alcohol withdrawal seizures Chronic alcoholic + poor nutrition  Onset: 12~48 hrs after a major decline in blood alcohol levels recent & decreased  6.2% 1st-time seizure related to alcohol carbohydrate intake had intracranial lesions  Tx: lorazepam depletion of glycogen stores  Anticonvulsant duration: 15 min for diazepam vs 12 hrs for lorazepam & reduced insulin production  If lorazepam not used, 8 times more likely to have 2nd seizure Lipolysis  free fatty acids

AKA: symptoms AKA: signs  Volume depletion – , orthostatic Anorexia and nausea  Odor of ketones Protracted vomiting  Tachypnea and/or Kussmaul respirations (rapid and deep breathing) Diffuse abdominal pain  Metabolic - Reduce oral intake  Fever is generally absent  Mental status usually normal Lipolysis  unless co-existing sepsis or hypoglycemia  Diffuse abdominal tenderness  can mimic and peritonitis

AKA: DDx AKA: lab tests

   Methanol or ethylene glycol ingestion  Hyponatremia  Iron overdose  Hypomagnesemia  Salicylate poisoning  Hypophosphatemia  Severe pancreatitis  Blood glucose variable  Ischemic bowel  Alcohol levels typically low or undetectable, however, AKA can occur high BALs AKA: ketones AKA: management

 A negative nitroprusside reaction does not  Cornerstones of therapy = volume repletion rule out ketoacidosis  Fluid resuscitation in AKA should include  nitroprusside reaction - sensitive for acetoacetate and acetone but not for ß- dextrose and saline hydroxybutyrate (BOHB, the major ketoacid in  Patients in AKA do not need insulin AKA)  Clinical response is the best way to follow  An increasingly positive nitroprusside the patient’s response to intervention reaction is consistent with an improvement rather than a worsening of the ketoacidosis  Supply potassium and magnesium  nitroprusside reaction becomes more positive as  Give thiamine the ß-hydroxybutyrate is metabolized to acetoacetate  Bicarbonates not indicated

Take home message Summary 1. ዚ╖ప៬ᰟ

2. ¹ᒻΏৈᙊɽዚ╖ᡛܾȚΥˢᾐ౳␯⊮

3. ᕓỚ AWS Ἔ drug of choice

4. AKA Ἔ኱ᜮᕓỚ

Take home message 1. ዚ╖ప៬ᰟ Thanks  20 mg/dL/h 2. ¹ᒻΏৈᙊɽዚ╖ᡛܾȚΥˢᾐ౳␯⊮  üᒻᡛܾ x 200 = ৈᙊᡛܾ 3. ᕓỚ AWS Ἔ drug of choice  Lorazepam 2~5 mg 4. AKA Ἔ኱ᜮᕓỚ  Dextrose+saline; no insulin'no Jusomin